Utilization of angiotensin-converting enzyme inhibitors (ACE-I) and/or TZD was also linked with a lower risk for incident asthma in obese/overweight patients with diabetes and/or hypertension, in another retrospective observational longitudinal data analysis, who included 77,278 Veterans with incident asthma [140]. The gene discussed is ACE; the disease is asthma.